Weekly Chemotherapy of 5‐Fluorouracil plus Cisplatin Concurrent with Radiotherapy for Esophageal Squamous Cell Carcinoma Patients with Postoperative Locoregional Recurrence: Results from a Phase II Study

Baoqing Chen; Qiwen Li; Qiaoqiao Li; Bo Qiu; Mian Xi; Mengzhong Liu; Yonghong Hu; Yujia Zhu

doi:10.1634/theoncologist.2019-0931

Weekly Chemotherapy of 5‐Fluorouracil plus Cisplatin Concurrent with Radiotherapy for Esophageal Squamous Cell Carcinoma Patients with Postoperative Locoregional Recurrence: Results from a Phase II Study

The Oncologist ◽

10.1634/theoncologist.2019-0931 ◽

2019 ◽

Vol 25 (4) ◽

pp. 308

Author(s):

Baoqing Chen ◽

Qiwen Li ◽

Qiaoqiao Li ◽

Bo Qiu ◽

Mian Xi ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Locoregional Recurrence ◽

Phase Ii Study ◽

Weekly Chemotherapy

Download Full-text

Concurrent radiotherapy with gefitinib in elderly patients with esophageal squamous cell carcinoma: Preliminary results of a phase II study

Oncotarget ◽

10.18632/oncotarget.5193 ◽

2015 ◽

Vol 6 (35) ◽

pp. 38429-38439 ◽

Cited By ~ 15

Author(s):

Yaping Xu ◽

Yuanda Zheng ◽

Xiaojiang Sun ◽

Xinmin Yu ◽

Jialei Gu ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Elderly Patients ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Preliminary Results ◽

Concurrent Radiotherapy

Download Full-text

A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-007-0577-6 ◽

2007 ◽

Vol 62 (1) ◽

pp. 77-84 ◽

Cited By ~ 28

Author(s):

Jeeyun Lee ◽

Young-Hyuck Im ◽

Eun Yoon Cho ◽

Yong Sang Hong ◽

Hyo Rak Lee ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

First Line ◽

Line Chemotherapy

Download Full-text

A randomized phase II study of leucovorin, 5-fluorouracil with or without oxaliplatin (LV5FU2 vs. FOLFOX) for curatively-resected, node-positive esophageal squamous cell carcinoma

Annals of Oncology ◽

10.1093/annonc/mdw371.35 ◽

2016 ◽

Vol 27 ◽

pp. vi218

Author(s):

S.H. Lim ◽

Y.-L. Choi ◽

S.-H. Jung ◽

M.-J.A. Ahn ◽

K. Park ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Node Positive ◽

Randomized Phase Ii ◽

Resected Node

Download Full-text

Nal-iri/lv5-fu versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI-PRODIGE 62): A FFCD multicenter, randomized, phase II study

Annals of Oncology ◽

10.1093/annonc/mdz247.168 ◽

2019 ◽

Vol 30 ◽

pp. v324

Author(s):

V. Randrian ◽

A. Adenis ◽

J. Desrame ◽

E. Barbier ◽

F. Di Fiore ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Second Line ◽

Second Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

Download Full-text

Elective lymph node irradiation late course accelerated hyper-fractionated radiotherapy plus concurrent cisplatin-based chemotherapy for esophageal squamous cell carcinoma: a phase II study

Radiation Oncology ◽

10.1186/1748-717x-8-108 ◽

2013 ◽

Vol 8 (1) ◽

pp. 108 ◽

Cited By ~ 5

Author(s):

Dongqing Wang ◽

Jiali Yang ◽

Jingyu Zhu ◽

Baosheng Li ◽

Limin Zhai ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Lymph Node ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Fractionated Radiotherapy ◽

Lymph Node Irradiation

Download Full-text

126P A phase II study of rh-endostatin combined with irinotecan plus cisplatin as the second-line treatment for advanced esophageal squamous cell carcinoma (ESCC)

Annals of Oncology ◽

10.1016/j.annonc.2020.10.147 ◽

2020 ◽

Vol 31 ◽

pp. S1292

Author(s):

J. Chang ◽

H. Wang ◽

Z. Hu ◽

J. Wang ◽

X. Wu ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Line Treatment ◽

Second Line

Download Full-text

Randomized phase II study of recombinant human endostatin combined with definitive chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.4035 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 4035-4035 ◽

Cited By ~ 2

Author(s):

Jiahua Lv ◽

Tao Li ◽

Xiaorong Deng ◽

Fang Li ◽

Yanqiong Song ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Locally Advanced ◽

Definitive Chemoradiotherapy ◽

Recombinant Human Endostatin ◽

Randomized Phase Ii

Download Full-text

W1883 Phase II Study of Photodynamic Therapy (PDT) for Local Failure After Chemoradiotherapy (CRT) in Patients With Esophageal Squamous Cell Carcinoma (ESCC)

Gastroenterology ◽

10.1016/s0016-5085(10)63496-8 ◽

2010 ◽

Vol 138 (5) ◽

pp. S-758-S-759 ◽

Cited By ~ 1

Author(s):

Tomonori Yano ◽

Manabu Muto ◽

Keiko Minashi ◽

Takashi Kojima ◽

Kazuhiro Kaneko ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Photodynamic Therapy ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Local Failure

Download Full-text

Regional Lymph-Node Failures after Diagnostic Endoscopic Resection Plus Selective Chemoradiotherapy for Clinical Stage I Esophageal Squamous Cell Carcinoma: A Multi-Institutional Phase II Study (JCOG0508)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2019.06.552 ◽

2019 ◽

Vol 105 (1) ◽

pp. S84-S85

Author(s):

K. Nihei ◽

K. Minashi ◽

K. Takizawa ◽

G. Ogawa ◽

T. Yano ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Lymph Node ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Endoscopic Resection ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Regional Lymph Node ◽

Clinical Stage

Download Full-text

Recombinant human endostatin plus paclitaxel/nedaplatin for recurrent or metastatic advanced esophageal squamous cell carcinoma: a prospective, single-arm, open-label, phase II study

Investigational New Drugs ◽

10.1007/s10637-020-01021-1 ◽

2020 ◽

Author(s):

Zhi-Qiang Wang ◽

De-Shen Wang ◽

Feng-Hua Wang ◽

Chao Ren ◽

Qiong Tan ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Open Label ◽

Recombinant Human Endostatin ◽

Open Label Phase

Download Full-text